Why patient advocates are key to growing CBD brands
Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.
Up in smoke: Understanding knowledge gaps for cannabis edibles
Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.
The cultivation of sustainable and organic medical cannabis in controlled environments
CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.
Sovereignport discuss their CBD and Hemp supply chain
Speaking with Sarah Yetman, CEO of Sovereignport, we understand how she pioneered a CBD and hemp supply chain that is surviving COVID-19 measures.
Cannyx Markets UK Ltd: The globalisation of the CBD industry
Here, Hassan Akhtar explains how Cannyx Markets UK Ltd. Are successfully navigating the globalisation of the CBD industry.
Professor Mike Barnes: The future of medical cannabis is real
We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.
Cannabinoids in medicine part 4: Epilepsy
In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.
Malta’s stance on cannabis for medicinal and research purposes
Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.
Setting global standards for CBD quality and compliance
At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.
The FDA’s 2020 Cannabis policy
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.
Standardised extracts are the future of the CBD industry
Following the latest legislative and market trends, Ilesol Pharmaceuticals has developed a new product with a shiny future in the CBD industry.
Removing the barriers to ensure a thriving UK hemp industry
Rebekah Shaman, Managing Director at British Hemp Alliance, explains what we need to know about removing the barriers to ensure a thriving UK hemp industry.
Cannabis (hemp): The effect of terpenes in CBD full extracts
Cannabis (hemp) contains up to 150 different terpenes. They not only determine the smell, but they also have valuable properties for the body as studies show. Katharina Zedlacher, from BioBloom GmbH, discusses the effect of terpenes in CBD full extracts.
Topical Cannabis-Based Medicines (TCBM): A novel epigenetic paradigm for wound management
Dr Vincent Maida discusses his discoveries and pioneering research in the area of using Topical Cannabis-Based Medicines (TCBM) for integumentary and wound management.
Naturalis London: Providing quality CBD
Joe Seaman, Head of Client Relations at Naturalis London, tells us how the firm is providing quality CBD, trusted education and tailored consumer advice.
Is it safe to drive after taking CBD?
Two-Fifths of Brits think it is “not safe” to drive after taking CBD, according to YouGov study.
How can medical marijuana help people lose weight?
Michael Jacobs, marketing and creative content specialist at GotVape.com offers his insight into how medical marijuana has the potential to help people lose weight.
CND session of March 2020: Low THC products?
Here Kathleen Denoodt explains the role of ECDD and why she believes the recommendations of the investigative report should be followed.
Have you heard about the uses of Hemp?
Sara Marie Williams, founder of Hemp for Healthcare in Alaska, discusses the practical uses of Hemp.
Brits in high-stress careers would consider CBD oil for mental health
More than a fifth of Brits say they work more than 50 hours a week in high-stress careers, leading to an increase in cases of anxiety and depression.
